| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 25, 2026 | Aggreko NYSE IPO Reveals AI Data Centers at 19% of Sales; Oura Targets $16B Listing | By Jerry Owens
Published: Aug 25 2026, 2:56 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| Aug 25, 2026 | Ehrmann Family To Increase Artmarket.com Stake As Artprice Advances AI-First Transformation | Artmarket.com founder and CEO Thierry Ehrmann and his family plan to increase their ownership of the company as Artprice invests in proprietary vertical artificial intelligence technologies.
The company said the purchases are intended to de... |
| Aug 6, 2026 | Canada Over MiCA: What’s Really Driving Crypto Projects in 2026, per SBSB’s Yuliya Barabash | You may have noticed the growing conversation about MiCA’s demanding requirements and the search for alternatives lately. And so, you may be wondering where crypto projects are heading now.
Despite all the hype around Europe’s gold standard... |
| Mar 16, 2026 | SwissBorg secures MiCA approval from French AMF |
With MiCA, the EU introduced the first uniform regulation for crypto-assets. It defines the rules for the offer to the public and admission to trading. To operate under this new European framework, SwissBorg’s MiCA authorisation has been o... |
| Mar 12, 2026 | France : AMF Study Highlights Stable Yet Shifting Landscape of French Equity Market Participants | France’s financial regulator, the Autorité des Marchés Financiers (AMF), has released a detailed examination of who trades French equities and how their roles have evolved over the past five years. Covering 2019 through 2024, the review dra... |
| Jan 14, 2026 | French regulator says some crypto firms unresponsive as EU licence deadline approaches | PARIS, Jan 13 : Nearly a third of crypto companies without an EU licence in France are still to tell the regulator whether they intend to get the licence required under new EU rules or will cease operating by July, the country's markets reg... |
| Dec 17, 2025 | TV personalities and YouTubers back French accelerator Cube in €700k funding round | Angers-based tech accelerator Cube, formerly known as Cube3, has closed a €700k funding round as it doubles down on its hybrid accelerator model that merges business support, financing, and media production.
The company has attracted invest... |
| Oct 24, 2025 | Relai: MiCA license opens a gateway to Europe |
Since its inception in 2020 by Julian Liniger and Adem Bilican, Relai has been providing a Bitcoin-only app that allows anyone to buy and sell Bitcoin within minutes. With over 600,000 app downloads and over 90,000 users, the Swiss-license... |
| Jul 11, 2025 | France : AMF Updates Reveal Evolving Trends in Retail Investment and Regulatory Oversight | Listen to this article
0:00 / 5:28
1X BeyondWords
The Autorité des Marchés Financiers (AMF), France’s financial markets regulator, has released a series of reports and analyses that shed light on the evolving landscape of retail investment ... |
| Jun 4, 2025 | The Shifting Landscape of Real Estate Investments in Europe | The real estate market in Europe is evolving. Two recent transactions highlight this transformation. EQT Real Estate's acquisition of a logistics portfolio in Southern France and CapMan's strategic appointment of James O’Neill signal a shif... |
| Jun 4, 2025 | The Shifting Landscape of Commercial Real Estate: A Tale of Transformation | The commercial real estate market is undergoing a seismic shift. For the first time in decades, more office space is being removed than added. This change is not just a statistic; it’s a reflection of evolving work habits and economic reali... |
| Jun 2, 2025 | EQT Real Estate acquires a five-building logistics portfolio across three locations in Southern France | EQT Real Estate acquires a five-building logistics portfolio across three locations in Southern France
Mon, Jun 02, 2025 10:00 CET Report this content
Acquisition of five logistics assets totaling approximately 148,000 square meters
Let to ... |
| Feb 13, 2025 | Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report | Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Paris, February 13, 2025. Sanofi announces today the filing of its Form 20-F with the U.S. Securities and Exchange Com... |
| Nov 29, 2024 | Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre | Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre
Paris, le 29 novembre 2024 – 15H30
Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME) et EB Development annoncent le s... |
| Oct 22, 2024 | Eurobio Scientific: COMMUNIQUÉ DU 22 OCTOBRE 2024 RELATIF À LA MISE À DISPOSITION DE LA NOTE D’INFORMATION DANS LE CADRE DE L’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC INITIÉE PAR EB DEVELOPMENT | COMMUNIQUÉ DU 22 OCTOBRE 2024
RELATIF À LA MISE À DISPOSITION DE LA NOTE D’INFORMATION
DANS LE CADRE DE L’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC
INITIÉE PAR
EB DEVELOPMENT
AGISSANT DE CONCERT AVEC IK X LU... |
| Oct 22, 2024 | OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC INITIÉE PAR LA SOCIÉTÉ EB DEVELOPMENT - Communiqué de mise à disposition du public de la note en réponse de la société Eurobio Scientific SA | COMMUNIQUÉ DU 22 OCTOBRE 2024
OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC
INITIÉE PAR LA SOCIÉTÉ EB DEVELOPMENT
AGISSANT DE CONCERT AVEC IK X LUXCO 3 S.A R.L, EUROBIONEXT, FPCI PEPITES ET TERRITOIRES, NEXTSTAG... |
| May 19, 2024 | Autorité des Marchés Financiers (AMF) Announces Appointments of France Mayer As Retail Investor Relations and Protection Director | France Mayer has reportedly been appointed Retail Investor Relations and Protection Director at the Autorité des Marchés Financiers (AMF).
France Mayer is currently Market Intermediaries Supervision Director “at the Data and Markets Directo... |
| Apr 29, 2024 | Crypto Banking Firm BCB Group Secures Digital Asset and Electronic Money License in France
How Wars Could Impact Bitcoin's Value | France will serve as BCB’s regulatory base in Europe.
The payments firm has been authorized as an Electronic Money Institution and Digital Assets Services Provider.
Jerome Prigent was appointed as MD of BCB Europe in December to drive the c... |
| Feb 23, 2024 | Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report | Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Paris, February 23, 2024. Sanofi announces today the filing of its Form 20-F with the U.S. Securities and Exchange Com... |
| Feb 23, 2024 | Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel, et du « Form 20-F » américain | Dépôt du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
Paris, le 23 février 2024. Sanofi annonce avoir déposé son Document d’Enregistrement Universel 2023 contenant le Rapport... |
| Nov 14, 2023 | Blockchain.com $110M funding round halves its 2022 valuation: Report
Delaware authorities refer fake BlackRock XRP trust filing to state’s Justice Department
How this all-in-one app bridges the gap between traditional banking and crypto
Tornado Cash users file appeal over judgment in favor of ...... | Crypto exchange and wallet provider Blockchain.com closed a $110-million Series E financing round, an investment that more than halves its previous 2022 valuation of $14 billion.
In a Nov. 14 blog post, Blockchain.com said the closing of it... |
| Nov 14, 2023 | Uniswap launches Android wallet app with built-in swap function
Animoca eyes SportFi ecosystem, becomes Chiliz Chain validator
Privacy-first, copyright-friendly content is key to driving Web3 adoption
FTX, BlockFi claims settlement allowed to proceed, judge declares
How this decentralized so ... | Uniswap Labs has publicly released an Andriod mobile wallet app with built-in swap capability on the Google Play store.
The new app allows users to make swaps through the decentralized exchange (DEX) from within the app, eliminating the nee... |
| Nov 14, 2023 | FTX, BlockFi claims settlement allowed to proceed, judge declares
Tether credits USDT growth surge to ETF excitement, emerging markets
How this decentralized social media platform plans to bring the next billion users to Web3
Ripple exec reiterates need for tech-neutral crypto regulations
Ho ... | Bankrupt crypto companies FTX and BlockFi are allowed to proceed in negotiations for their claims settlement, according to a new court filing.
On Nov. 13, United States bankruptcy Judge Michael Kaplan ordered the end of an automatic holding... |
| Nov 14, 2023 | Owner of Hong Kong crypto exchange OSL secures $90M investment
Swan Bitcoin to terminate customer accounts that use crypto-mixing services
Privacy-first, copyright-friendly content is key to driving Web3 adoption
NFT sales volume upward trend to continue, industry execs say
How this all-in-o ... | BC Technology Group, the operator of Hong Kong’s publicly listed cryptocurrency exchange OSL, has announced a significant investment from industry firm BGX.
BC Technology entered into a partnership with BGX, which agreed to subscribe for sh... |
| Sep 14, 2023 | French fintech Fipto secures €15M for instant payments using blockchain tech | Today French Treasury management fintech Fipto has raised €15 million in Seed funding.
Fipto is a global B2B payments and treasury management solution which enables companies to manage corporate treasuries and to make instant international ... |
| Aug 10, 2023 | France Steps Closer to Implementing MiCA for Crypto Firms | France has amended its registration requirements for crypto firms to better align with the European Union's new regulations for the sector, the country's financial regulator AMF announced on Thursday.
Countries in the EU are preparing to im... |
| Jul 26, 2023 | Crypto Must Take Fraud Prevention Seriously: Crypto Long & Short | For months, the crypto landscape has been plagued by regulatory uncertainty. Recent events, including the split Ripple decision, the indictment of Celsius’ former CEO and competing congressional bills serve as reminders of the pressing need... |
| Jul 23, 2023 | Банк Societe Generale впервые во Франции получил высокий статус «аккредитованного» Поставщика услуг цифровых активов | Французский банковский гигант Societe Generale официально заявил о серьёзности своих амбиций в сфере криптовалютных активов. Societe Generale-FORGE (SG-FORGE), дочерняя компания банковской группы, занимающаяся криптовалютами и функционирующ... |
| Mar 10, 2023 | Современное регулирование цифровых активов во Франции | Растущее количество случаев мошенничества с криптовалютами заставило правительство переосмыслить законодательные недостатки и более эффективно устранять риски, связанные с цифровыми активами, поскольку французское законодательство не призна... |
| Feb 24, 2023 | ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS) | /EIN News/ --
FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection. This positive event triggers impairment reversal, impacting 2022 IFRS net income; no change on ... |
| Feb 24, 2023 | ALTUVIIIO™ approuvé par la FDA américaine : cet événement positif déclenche une reprise de dépréciation, ce qui a un impact positif sur le résultat net IFRS 2022 ; aucun changement sur le résultat net des activités (non-IFRS) | /EIN News/ --
La FDA américaine approuve ALTUVIIIOTM une fois par semaine, une nouvelle classe de facteur VIII pour le traitement de l’hémophilie A qui confère une protection significative contre les saignements. Cet événement positif décle... |
| Jan 24, 2023 | MiCA at the Door: How European Crypto Firms Are Getting Ready for Sweeping Legislation | The European Union’s sweeping Market in Crypto-Assets (MiCA) legislation is slowly moving toward becoming law, and local crypto companies are getting ready for the change. The new regulations, which will be the law for all 27 EU member coun... |
| Oct 17, 2022 | Societe Generale's Crypto Division Forge Secures Registration With French Regulator | Societe Generale's crypto division SG Forge has won registration from France's Autorité des Marchés Financiers (AMF) for cryptocurrency custody and trading services.
The French banking giant's crypto subsidiary is registered to offer buying... |
| Sep 30, 2022 | Valneva Announces Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares | Saint Herblain (France), September 30, 2022 – Valneva SE VALNVLA (the "Company"), a specialty vaccine company, announced today the pricing of 21,000,000 ordinary shares in a global offering to specified categories of investors com... |
| Sep 19, 2022 | Instabox and Budbee join hands to give an extra push to last-mile delivery | As the last-mile delivery space market gets more intense, two Swedish-founded last mile delivery companies Instabox and Budbee have joined forces under a new holding company, Instabee to boost e-commerce shipping. The new group is expected ... |
| May 5, 2022 | Binance Acquires French Regulatory License in EU Push | Leading global cryptocurrency exchange Binance has received approval from the French Financial Service Coordinator, Autorité des marchés financiers (AMF), according to a Wednesday release from the financial market watchdog. Binance Bags Fir... |
| May 4, 2022 | Binance Secures Regulatory Approval in France | Cryptocurrency exchange Binance has secured regulatory approval in France, according to a release from France's capital market regulator, the AMF (Autorité des marchés financiers).
Binance is now a registered Digital Asset Service Provider ... |
| Feb 4, 2022 | Innate Pharma : to Participate in Upcoming Investor Conferences - Form 6-K | Innate Pharma to Participate in Upcoming Investor Conferences
MARSEILLE, France--(BUSINESS WIRE)--February 4, 2022--Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today ... |
| Jan 6, 2022 | INNATE PHARMA OBTAINS EUR28.7M IN NON- DILUTIVE FINANCING IN THE FORM OF STATE GUARANTEED LOANS | Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company') announced that it has obtained EUR28.7M in non-dilutive financing in the form of two loans from Societe Generale and BNP Paribas.
The two loans have an initial... |
| Jan 5, 2022 | Innate Pharma : Obtains 28.7m in Non-Dilutive Financing in the Form of State Guaranteed Loans - Form 6-K | Innate Pharma Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed Loans
Financing strengthens Company's cash horizon
MARSEILLE, France--(BUSINESS WIRE)--January 5, 2022--Regulatory News:
Innate Pharma SA (Euronext Paris... |
| Jan 4, 2022 | Innate Pharma : to Participate in Upcoming Investor Conferences - Form 6-K | Innate Pharma to Participate in Upcoming Investor Conferences
MARSEILLE, France--(BUSINESS WIRE)--January 4, 2022--Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today a... |
| Dec 28, 2021 | The ACPR and AMF publish their report on climate-related commitments of French financial institutions | Paris, 28 December 2021
The ACPR and AMF publish their report on climate-related commitments of French financial institutions
Following the publication end of October 2021 of a pre-report on sectoral policies relating to fossil fuels, the A... |
| Dec 23, 2021 | 2021 report on corporate governance and executive compensation in listed companies | amf-france.org
EXECUTIVE SUMMARY
SECTION 1: RECENT DEVELOPMENTS IN GOVERNANCE
The first section of the report focuses on news and recent developments in governance.
Once again this year, due to the ongoing health crisis and the resulting ch... |
| Dec 21, 2021 | Speech by Benoît de Juvigny, AMF Secretary General - IOSCO SPAC Network Stakeholder Meeting - 16 December 2021 | Speech by Benoît de Juvigny, AMF Secretary General - IOSCO SPAC Network Stakeholder Meeting - 16 December 2021
Check against delivery Introduction
Delighted to participate in this IOSCO outreach event dedicated to the topic of SPACs. Acknow... |
| Dec 17, 2021 | Innate Pharma - FIRST PATIENT DOSED IN IPH6101/SAR443579, PHASE 1/2 CLINICAL TRIAL IN VARIOUS BLOOD CANCERS | Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company') announced that the first patient was dosed in a Phase 1/2 clinical trial (NCT05086315), evaluating IPH6101/SAR443579, the first NKp46/CD16-based NK cell engage... |
| Dec 16, 2021 | Innate Pharma : - Form 6-K | Innate Pharma: First Patient Dosed in IPH6101/SAR443579 Phase 1/2 Clinical Trial in Various Blood Cancers
Partner Sanofi advances IPH6101/ SAR443579, a novel NKp46/CD16-based, CD123 targeted NK cell engager, to first-in-human clinical trial... |
| Dec 16, 2021 | Financial and non-financial overview of corporate carbon reporting | Financial and non-financial overview of corporate carbon reporting
INTRODUCTION
Introduction
This report follows on from the four reports on corporate social, societal and environmental responsibility previously published by the Autorité de... |
| Dec 9, 2021 | Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress - Form 6-K | Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress
First chemo-free triplet shows preliminary a... |
| Dec 7, 2021 | The AMF's latest savings barometer finds that the French are more receptive to equities | The AMF's latest savings barometer finds that the French are more receptive to equities
The fifth edition of the AMF savings and investment barometer shows an increase in intentions to subscribe to equity investments, particularly among you... |
| Dec 2, 2021 | Innate Pharma : to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress - Form 6-K | Innate Pharma to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress
Innate to present new Phase 2 data on the combination of monalizumab, cetuximab and durvalumab in head and neck cancer in an oral presentation
ANKETTM to be hig... |
| Nov 30, 2021 | Tronics Microsystems : TRONICS ANNOUNCES SUCCESSFUL COMPLETION OF EUR 28.9 MILLION CAPITAL INCREASE | Grenoble, France and Dallas TX, USA - November 30, 2021 – Tronics, a TDK Group company that manufactures custom MEMS products and standard inertial sensors for industrial applications, today announces the successful completion of its capita... |
| Nov 24, 2021 | Innate Pharma : to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conference - Form 6-K | Innate Pharma to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conference
MARSEILLE, France--(BUSINESS WIRE)--November 24, 2021--Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or th... |
| Nov 16, 2021 | Innate Pharma : Third Quarter 2021 Report - Form 6-K | Innate Pharma Third Quarter 2021 Report
Monalizumab in combination with durvalumab significantly delayed disease progression in AstraZeneca's randomized Phase 2 COAST study in unresectable, Stage III NSCLC, advancing to Phase 3
Pre-clinical... |
| Nov 9, 2021 | Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update - Form 6-K | Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update
MARSEILLE, France--(BUSINESS WIRE)--November 9, 2021--Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Com... |
| Nov 8, 2021 | Sales for the 1st quarter 2021-2022 – press release | Vilmorin & Cie SA
Public limited company with Board of Directors with a capital of 349,488,703 euros
Head Office: 4, Quai de la Mégisserie - F-75001 PARIS SIREN Paris 377 913 728
Fiscal year from July 1st to June 30th
Euronext Paris (Co... |
| Nov 5, 2021 | Tronics Microsystems : TRONICS LAUNCHES A CAPITAL INCREASE OF EUR 28.9 MILLION WITH PREFERENTIAL SUBSCRIPTION RIGHTS FOR ALL SHAREHOLDERS | Subscription price: €5.40 per new share
Subscription ratio: 16 new shares for 11 existing shares
Detachment of preferential subscription rights on November 10, 2021 and subscriptions open from November 12 to 25, 2021 inclusive
Subscription ... |
| Nov 3, 2021 | Second ACPR and AMF's joint report on the monitoring and assessment of the climate-related commitments of French financial institutions: sectoral policies and fossil fuel exposure of market participants | Second ACPR and AMF's joint report
Sectoral policies and fossil fuel
exposure of French financial market
participants
Pre-report
Extract from the ACPR-AMF joint report on the assessment of the climate-related commitments of French
financial... |
| Oct 28, 2021 | Third quarter 2021 results: performance above expectations, due to structural measures as well as favourable conjunctural business environment | Press Release Paris - October 28th, 2021
THIRD QUARTER 2021 RESULTS
PERFORMANCE ABOVE EXPECTATIONS, DUE TO STRUCTURAL MEASURES AS WELL AS FAVOURABLE
CONJUNCTURAL BUSINESS ENVIRONMENT
RECORD CORPORATE EBITDA MARGIN AT 27.4 %
RAISED AMBITIONS... |
| Oct 26, 2021 | Innate Pharma 2022 Financial Calendar - Form 6-K | Innate Pharma 2022 Financial Calendar
MARSEILLE, France--(BUSINESS WIRE)--October 26, 2021--Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2022 financ... |
| Oct 26, 2021 | Waga Energy : Waga Energy announces the resounding -2- | and Starquest: 360 calendar days following thesettlement/delivery date of the Offering, subject to certain usual exceptions. ? Holding commitments of Noria, Tertium, Swift and Mr Benoit Lemaignan: 180 calendar days following thesettlement/d... |
| Oct 22, 2021 | Prodware : Phast Invest and Prodware's historical and leading shareholders announce the filing of a takeover bid for Prodware shares | Do not disseminate in the United States, Canada, Japan, Australia or South Africa.
This press release does not constitute an offer to purchase securities.
A public limited company (société anonyme) A public limited company (société anonyme)... |
| Oct 18, 2021 | Voluntis : Voluntis announces the success of the Tender Offer initiated by the company Aptar allowing the implementation of mandatory squeeze-out | Cambridge (USA), Paris (France), October 18, 2021 - Voluntis (Euronext Growth Paris, Ticker: ALVTX - ISIN: FR0004183960 - "the Company"), a leader in the field of digital therapeutics, announces the successful completion of the Si... |
| Oct 18, 2021 | EuropaCorp : Universal Registration Document 2020/2021 (translation) | French public limited company (Société anonyme)
with a Board of Directors
and share capital of €41,514,758.54 Registered office: 20 rue Ampère 93200 Saint-Denis - France
RCS Bobigny 384 824 041
UNIVERSAL REGISTRATION DOCUMENT
This Universal... |
| Oct 18, 2021 | Voluntis : announces the success of the Tender Offer initiated by the company Aptar allowing the implementation of mandatory squeeze-out | home
News
Voluntis announces the success of the Tender Offer initiated by the company Aptar allowing the implementation of mandatory squeeze-out
Voluntis announces the success of the Tender Offer initiated by the company Aptar allowing the ... |
| Oct 14, 2021 | The AMF publishes the initial conclusions of the Climate and Sustainable Finance Commission on the carbon neutrality of companies | The AMF publishes the initial conclusions of the Climate and Sustainable Finance Commission on the carbon neutrality of companies
The report of the AMF's Climate and Sustainable Finance Commission sheds light on the carbon neutrality approa... |
| Oct 14, 2021 | Companies and carbon neutrality: initial conclusions and issues identified | This document is the result of discussions, research and exchange with experts conducted by a working group set up in March 2021 and composed of members of the AMF Climate and Sustainable Finance Commission. The Climate and Sustainable Fina... |
| Oct 14, 2021 | Waga Energy : Waga Energy announces the launch of -2- | Waga Energy estimates that there are 20,000 waste storage sites around the world. Less than 1% of the gas produced is currently converted into biomethane, illustrating the immense potential offered by the WAGABOX(R) solution. Waga Energy pr... |
| Oct 1, 2021 | Quadient S A : September 30, 2021 Availability of the 2021 haf-year financial report | REGULATED INFORMATION
Press release related to the availability of the half-year financial report
Quadient: Availability of
the 2021 half-year financial report
Paris, 30 September 2021,
Quadient (Euronext Paris: QDT) announces that it has f... |
| Oct 1, 2021 | 01-10-2021 : RESULTS FOR THE FIRST NINE MONTHS OF FISCAL YEAR 2021 | Press release
Paris, October 1, 2021
RESULTS FOR THE FIRST NINE MONTHS
OF FISCAL YEAR 2021
Housing property portfolio of 35,034 units, i.e. approximately €8.1 billion, including VAT, in potential revenue
Overall backlog: €3.4 billion
Financ... |
| Sep 30, 2021 | Abivax : announces the release of its half-year financial report 2021 | PARIS, France, September 30, 2021 - 6:00 pm (CEST) - Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, ... |
| Sep 29, 2021 | Waga Energy : Waga Energy's universal registration -2- | In addition to the environmental benefits of its technology, Waga Energy is committed to social responsibility. In September 2021, the Ethifinance rating agency awarded the company a score of 69/100 for its "advanced" non-financia... |
| Sep 17, 2021 | Innate Pharma : Monalizumab Data from COAST Trial Presented at ESMO Congress 2021 | MARSEILLE, France, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that AstraZeneca (LSE/STO/Nasdaq: AZN) presented results from the randomized COAST Phase ... |
| Sep 17, 2021 | Innate Pharma : Monalizumab Data from COAST Trial Presented at ESMO Congress 2021 (Form 6-K) | Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
MARSEILLE, France, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company') today announced that AstraZeneca (LSE/S... |
| Sep 15, 2021 | Innate Pharma : Reports First Half 2021 Financial Results and Business Update | First data set from lacutamab TELLOMAK trial demonstrated encouraging 35% overall global response rate, including skin improvement in patients with mycosis fungoides that express KIR3DL2New pre-clinical data presented from next-generation N... |
| Sep 15, 2021 | INNATE PHARMA : REPORTS FIRST HALF 2021 FINANCIAL RESULTS AND BUSINESS UPDATE (Form 6-K) | INNATE PHARMA REPORTS FIRST HALF 2021 FINANCIAL RESULTS AND BUSINESS UPDATE
•First data set from lacutamab TELLOMAK trial demonstrated encouraging 35% overall global response rate, including skin improvement in patients with mycosis fungoid... |
| Sep 7, 2021 | Innate Pharma : Announces Conference Call and Webcast for First Half 2021 Business Update (Form 6-K) | Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
MARSEILLE, France, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company'), today announced ... |
| Sep 7, 2021 | Innate Pharma : Announces Conference Call and Webcast for First Half 2021 Business Update | Marseille, France, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Wednesday, September 15, 2021, at 2 p.m.... |
| Sep 2, 2021 | Innate Pharma : Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress | Marseille, France, Sept. 02, 2021 (GLOBE NEWSWIRE) -- AstraZeneca to present new data on monalizumab in combination with durvalumab in a late-breaking abstract on COAST Phase 2 trial
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“In... |
| Sep 2, 2021 | Innate Pharma : AstraZeneca to present new data on monalizumab in combination with durvalumab in a late-breaking abstract on COAST Phase 2 trial (Form 6-K) | AstraZeneca to present new data on monalizumab in combination with durvalumab in a late-breaking abstract on COAST Phase 2 trial
MARSEILLE, France, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('In... |
| Aug 30, 2021 | Innate Pharma : to Participate in Upcoming Investor Conferences | Marseille, France, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participa... |
| Aug 30, 2021 | Innate Pharma : to Participate in Upcoming Investor Conferences (Form 6-K) | Innate Pharma to Participate in Upcoming Investor Conferences
MARSEILLE, France, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH - ISIN: FR0010331421; Nasdaq: IPHA) ('Innate' or the 'Company') today announced that me... |
| Aug 26, 2021 | Iliad : Press release relating to the filing of the draft response document prepared by iliad in response to the simplified tender offer for the shares of iliad initiated by Holdco II | PRESS RELEASE RELATING TO THE FILING OF THE DRAFT RESPONSE DOCUMENT PREPARED BY: ILIAD
IN RESPONSE TO
THE SIMPLIFIED TENDER OFFER FOR THE SHARES OF ILIAD
INITIATED BY:
HOLDCO II
AMF
This press release was prepared by Iliad and distributed o... |
| Aug 4, 2021 | Safran : announces the availability of its 2021 Interim Financial Report | PRESS RELEASE
Safran announces the availability of its 2021 Interim Financial Report
Paris, August 4, 2021
Safran (Euronext Paris: SAF) has filed the French version of its 2021 Interim Financial Report (Rapport Financier Semestriel) with th... |
| Jul 31, 2021 | AtoS : Amendment to the 2020 Universal Registration Document including the 2021 half-year financial report | Amendment to the 2020 Universal
Registration Document (URD)
Including the 2021
half-year financial report
Only the French version of the amendment to the 2020 Universal Registration Document has been submitted to the Autorité des Marchés Fi... |
| Jul 30, 2021 | Iliad : Press release concerning the availability of the prospectus drawn up by Holdco II | PRESS RELEASE DATED JULY 30, 2021
SIMPLIFIED TENDER OFFER FOR THE SHARES OF
ILIAD
INITIATED BY THE COMPANY
HOLDCO II
PRESENTED BY
BNP PARIBAS CREDIT AGRICOLE CORPORATE & INVESTMENT BANK SOCIETE GENERALE
FINANCIAL ADVISORS
PRESENTING BAN... |
| Jul 30, 2021 | Worldline : Amendment of the 2020 Universal Registration Document | AMENDMENT OF THE 2020 UNIVERSAL REGISTRATION DOCUMENT
INCLUDING THE HALF-YEAR FINANCIAL REPORT
This document is a translation into English of the Universal Registration Document of the Company issued in French and it is available on the web... |
| Jul 7, 2021 | NACON : Universal Registration Document (URD) | NACON
Société anonyme governed by a Board of Directors with share capital of €84,908,919
Registered office: 396/466, Rue de la Voyette, CRT 2, 59273 Fretin, France
Registration number: 852 538 461 RCS Lille Métropole
(the "Company"... |
| Jul 6, 2021 | Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia | Investigator-sponsored FORCE trial did not meet primary endpoints
Company will stop exploring avdoralimab in COVID-19
Investigator-sponsored avdoralimab clinical trial in inflammation will continue
MARSEILLE, France, July 06, 2021 (GLOBE NE... |
| Jul 6, 2021 | Innate Pharma : Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia (Form 6-K) | Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
Investigator-sponsored FORCE trial did not meet primary endpoints
Company will stop exploring avdoralimab in COVID-19
Investigator-sponsored avdoralimab cl... |
| Jun 30, 2021 | For the first time, the AMF approves a bond prospectus that allows the listing of Sustainable Linked Bonds on Euronext Paris | For the first time, the AMF approves a bond prospectus that allows the listing of Sustainable Linked Bonds on Euronext Paris
Sustainable-Linked Bonds (SLB) are debt securities with a financial incentive for the issuer to commit to a more 's... |
| Jun 26, 2021 | AMF Financial Markets Authority of French Re : The AMF Enforcement Committee fines a shareholder for several breaches of its reporting obligations in the context of a takeover bid | The AMF Enforcement Committee fines a shareholder for several breaches of its reporting obligations in the context of a takeover bid
In its decision of 17 June 2021, the Enforcement Committee fined Consellior SAS €80,000 for filing late rep... |
| Jun 22, 2021 | Innate Pharma : presents preliminary data from TELLOMAK trial showing clinical response for lacutamab in mycosis fungoides | Marseille, June 22, 2021 (GLOBE NEWSWIRE) -- First data set from TELLOMAK establishes safety, clinical responses and skin improvement in patients with mycosis fungoides that express KIR3DL2
Data support continued development of lacutamab fo... |
| Jun 22, 2021 | Results presented at 16th International Conference on Malignant Lymphoma; Innate to host investor event tomorrow, June 23, at 2:00 p.m. CEST / 8:00 a.m. EDT (Form 6-K) | Results presented at 16thInternational Conference on Malignant Lymphoma; Innate to host investor event tomorrow, June 23, at 2:00 p.m. CEST / 8:00 a.m. EDT
MARSEILLE, France, June 22, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Pari... |
| Jun 16, 2021 | INNATE PHARMA
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy | MARSEILLE, France, June 16, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that it will host a virtual investor event on Wednesday, June 23, 202... |
| Jun 16, 2021 | INNATE PHARMA
Innate Pharma : Company to highlight lacutamab data in mycosis fungoides and share data on its next-generation NK cell engager platform, ANKET (Form 6-K) | Company to highlight lacutamab data in mycosis fungoides and share data on its next-generation NK cell engager platform, ANKET™
MARSEILLE, France, June 16, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH - ISIN: FR0010331421;... |
| Jun 15, 2021 | AMF Financial Markets Authority of French Re : Ombudsman Annual Report 2020 | Ombudsman's Report 2020
WHO IS THE AMF OMBUDSMAN?
Marielle Cohen-Branche was first named AMF Ombudsman on 16 November 2011. Her appointment has since been renewed, most recently on 12 November 2018 for a further three years.
In accordance w... |
| Jun 11, 2021 | AMF Financial Markets Authority of French Re : Initial analysis of SFTR reporting data | JUNE 2021
INITIAL ANALYSIS OF SFTR REPORTING DATA
ARI EZRA, FLORENCE PEPIN, MYRIAM DENEUT
This study was carried out by the Data and Surveillance Directorate. It is based on sources that are considered to be reliable but whose comprehensive... |
| Jun 10, 2021 | INNATE PHARMA
Innate Pharma : Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting (Form 6-K) | Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
Proprietary, multi-specific NK cell engager platform, ANKET™, to generate next wave of immunotherapy molecules
ANKET is first NK cell e... |
| Jun 10, 2021 | INNATE PHARMA
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting | Proprietary, multi-specific NK cell engager platform, ANKET™, to generate next wave of immunotherapy molecules
ANKET is first NK cell engager technology to engage NKp46, CD16, IL-2 variant and tumor antigen in a single tetra-specific molecu... |
